TY - JOUR
T1 - Discussing Personalized Prognosis Empowers Patients with Amyotrophic Lateral Sclerosis to Regain Control over Their Future
T2 - A Qualitative Study
AU - van Eenennaam, Remko M
AU - Koppenol, Loulou S
AU - Kruithof, Willeke J
AU - Kruitwagen-van Reenen, Esther T
AU - Pieters, Sotice
AU - van Es, Michael A
AU - van den Berg, Leonard H
AU - Visser-Meily, Johanna M A
AU - Beelen, Anita
N1 - Funding Information:
Funding: This study was funded by The Netherlands ALS foundation (No. 2016–51).
Funding Information:
This study was funded by The Netherlands ALS foundation (No. 2016?51). The authors would like to thank all patients and caregivers who participated in the interviews for this study. Additionally, we would like to thank Anne-Wil Koopman (rehabilitation physician at Basalt rehabilitation, Leiden, The Netherlands), and Mark Janse van Mantgem (neurolo-gist at University Medical Center Utrecht, The Netherlands); both contributed to the inclusion and participated in our focus group.
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/12
Y1 - 2021/12
N2 - The ENCALS survival prediction model offers patients with amyotrophic lateral sclerosis (ALS) the opportunity to receive a personalized prognosis of survival at the time of diagnosis. We explored experiences of patients with ALS, caregivers, and physicians with discussing personalized prognosis through interviews with patients and their caregivers, and in a focus group of physicians. Thematic analysis revealed four themes with seven subthemes; these were recognized by the focus group. First, tailored communication: physician's communication style and information provision mediated emotional impact and increased satisfaction with communication. Second, personal factors: coping style, illness experiences, and information needs affected patient and caregiver coping with the prognosis. Third, emotional impact ranged from happy and reassuring to regret. Fourth, regaining control over the future: participants found it helpful in looking towards the future, and emphasized the importance of quality over quantity of life. Personalized prognosis can be discussed with minimal adverse emotional impact. How it is communicated-i.e., tailored to individual needs-is as important as what is communicated-i.e., a good or poor prognosis. Discussing personalized prognosis may help patients with ALS and their caregivers regain control over the future and facilitate planning of the future (care). For many patients, quality of life matters more than quantity of time remaining.
AB - The ENCALS survival prediction model offers patients with amyotrophic lateral sclerosis (ALS) the opportunity to receive a personalized prognosis of survival at the time of diagnosis. We explored experiences of patients with ALS, caregivers, and physicians with discussing personalized prognosis through interviews with patients and their caregivers, and in a focus group of physicians. Thematic analysis revealed four themes with seven subthemes; these were recognized by the focus group. First, tailored communication: physician's communication style and information provision mediated emotional impact and increased satisfaction with communication. Second, personal factors: coping style, illness experiences, and information needs affected patient and caregiver coping with the prognosis. Third, emotional impact ranged from happy and reassuring to regret. Fourth, regaining control over the future: participants found it helpful in looking towards the future, and emphasized the importance of quality over quantity of life. Personalized prognosis can be discussed with minimal adverse emotional impact. How it is communicated-i.e., tailored to individual needs-is as important as what is communicated-i.e., a good or poor prognosis. Discussing personalized prognosis may help patients with ALS and their caregivers regain control over the future and facilitate planning of the future (care). For many patients, quality of life matters more than quantity of time remaining.
KW - Amyotrophic lateral sclerosis
KW - Motor neuron disease
KW - Palliative care
KW - Prognosis
KW - Qualitative study
KW - Quality of life
UR - http://www.scopus.com/inward/record.url?scp=85122867849&partnerID=8YFLogxK
U2 - 10.3390/brainsci11121597
DO - 10.3390/brainsci11121597
M3 - Article
C2 - 34942899
SN - 2076-3425
VL - 11
SP - 1
EP - 16
JO - Brain sciences
JF - Brain sciences
IS - 12
M1 - 1597
ER -